{"acquisitions":[],"changes":[],"country":"US","description":"Veradermics is developing VDPHL01, a non-hormonal oral therapy for pattern hair loss, running three Phase 3 trials including the first US Phase 3 in female pattern hair loss. It targets men and women who want an oral alternative to topical minoxidil or hormonal finasteride. Large placebo-controlled trials aim for the first oral approval here in nearly 30 years.","domain":"veradermics.com","employees":null,"founded":2019,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":[],"lat":41.308214,"lng":-72.925052,"location":"New Haven, United States","multiples":[],"name":"Veradermics","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":75000000,"connectionsAmong":[],"currency":"USD","date":"2024-12-01","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"veradermics-com-2024-12-01-series-b","source":{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-04-29","status":"attributed","url":null},"status":"attributed","type":"series-b","url":null}],"slug":"veradermics-com","sources":[{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-04-29","status":"attributed","url":null},{"fact":"existence","publisher":"veradermics.com","retrievedAt":"2026-04-29","status":"self-reported","url":"https://veradermics.com"},{"fact":"description","publisher":"veradermics.com","retrievedAt":"2026-04-29","status":"self-reported","url":"https://veradermics.com"}],"stage":"series-b+","stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":["Nginx","WordPress 7.0","Magnific Popup 1.1.0","Yoast SEO 27.5","Google Tag Manager","imagesLoaded 5.0.0","Plesk","CookieYes","OWL Carousel","WP Rocket","PHP","MySQL"],"totalRaisedUsd":261180000,"traction":[],"updatedAt":"2026-04-29","valuations":[]}